The results of a number of investigations indicate that one feature of advanced renal failure is impaired ability to reject allogeneous tissue grafts. In 1955, Hume, Merrill, Miller, and Thorn reported the transplantation of kidneys from unrelated donors to nine patients with terminal renal failure (1). Four of the nine kidneys functioned for 5 to 25 weeks even though the therapy given to prevent graft rejection was inadequate by current standards. In a study of six uremic patients, Dammin, Couch, and Murray reported histological evidence of skin allograft survival for as long as 115 days (2). In view of these reports, and because a large number of patients were being evaluated for kidney transplantation, we have undertaken a detailed study of the effect of irreversible kidney failure on a number of parameters of immunological capability. Our earlier studies (3) indicated that chronically uremic patients have a suppression of immediate and delayed cutaneous hypersensitivity.
The results of a number of investigations indicate that one feature of advanced renal failure is impaired ability to reject allogeneous tissue grafts. In 1955, Hume, Merrill, Miller, and Thorn reported the transplantation of kidneys from unrelated donors to nine patients with terminal renal failure (1) . Four of the nine kidneys functioned for 5 to 25 weeks even though the therapy given to prevent graft rejection was inadequate by current standards. In a study of six uremic patients, Dammin, Couch, and Murray reported histological evidence of skin allograft survival for as long as 115 days (2) . In view of these reports, and because a large number of patients were being evaluated for kidney transplantation, we have undertaken a detailed study of the effect of irreversible kidney failure on a number of parameters of immunological capability. Our earlier studies (3) indicated that chronically uremic patients have a suppression of immediate and delayed cutaneous hypersensitivity.
Many features of delayed hypersensitivity are also characteristics of the allograft rejection phenomenon. In sitivity, and extracts of immunologically competent cells of immune animals will enhance allograft rejection by nonimmune animals (4, 5) . Because of the association between these two immunological reactions under experimental conditions, it seemed important to define their interrelationship as it applies to human kidney transplantation. The degree of suppression of delayed cutaneous hypersensitivity observed in a group of patients with advanced renal failure has been compared to the response of the group to allogeneous kidney grafts. Patients who demonstrated the most profound impairment of delayed cutaneous reactivity were also found to have the longest intervals between transplantation and the onset of the first immunologic reaction.
Methods
The subjects of this investigation were 26 patients with chronic renal insufficiency who were accepted for kidney transplantation. In most instances the uremia was the result of chronic glomerulonephritis. Three patients had polycystic kidney disease; two patients had chronic pyelonephritis; one patient had gouty nephropathy. Only a few patients had had renal biopsy in the earlier stages of their disease; however, the histologic nature of the renal lesion was characterized in all patients when their kidneys were removed in preparation for transplantation. The group consisted of 20 males and 6 females whose ages ranged from 6 to 54 years. The mean age was 30.8 years. The pertinent clinical features of the patients are summarized in Table I . The comparatively low values for blood urea nitrogen listed for some patients were obtained after hemodialyses. The values for endogenous creatinine clearance recorded for 19 patients document the marked reduction in functional renal mass that existed in these patients.
The ability of each patient in the group to manifest delayed cutaneous hypersensitivity was assessed before surgery and the administration of any drugs that are known to alter this immunologic reaction. For this evaluation, the cutaneous response to a panel of seven 1881 The kidney transplantation was performed on 26 donorrecipient pairs of whom 17 were genetically related.
In each instance a living donor was used. With the exception of Patient 3, the ABO blood group antigens of the donors were compatible with those of their recipients. The erythrocyte type of Patient 3 was 0, and he received a kidney from his mother whose type was A. His postoperative course is discussed in detail below.
At the conclusion of the preoperative studies, treatment with azathioprine1 was begun. The dose was usually 3 to 5 mg per kg per day. The patients were then subjected to splenectomy, bilateral nephrectomy, and renal transplantation as described by Starzl, Marchioro, and Waddell (6) . The duration of ischemia of the transplanted kidney was recorded at each operation. During the postoperative period the azathioprine treatment was continued. When attempted allograft rejection became apparent, prednisone and actinomycin C2 were added to the therapeutic regime.
The features that characterize the attempted rejection of a kidney allograft are fever, leukocytosis, fall in urine volume, decrease in endogenous creatinine clearance, decrease in urinary sodium excretion, and rise in blood urea nitrogen. A favorable response to treatment for attempted rejection supports the diagnosis. In this study the reaction time is defined as the number of days that elapsed after transplantation before these changes in status appeared and the therapy for reversal of the attempted rejection was begun. Figure 1 summarizes the postoperative course of Patient 22 whose rejection reaction was typical of that observed in the majority of the patients. His reaction time was recorded as 20 days. Unusual patterns of attempted rejection were suspected in Patients 3 and 24, and their postoperative courses are discussed below.
To define the relationship between suppression of delayed cutaneous hypersensitivity and attempted rejection of the kidney allograft, the recipients have been divided into two groups. Those patients who developed no reactions to the antigens have been designated the unresponsive group. The remaining patients, the responsive group, were those in whom a delayed reaction to at least one antigen appeared. The mean reaction time of each group was calculated. The groups were also compared with respect to their mean ages and to the mean duration of ischemia of the transplanted kidneys 
Results
The results of an earlier study indicated that delayed cutaneous hypersensitivity was suppressed in the chronically uremic patient. Because this observation has been reported in detail (3), the results in these 26 patients will be summarized only briefly here. Figure 2 illustrates the percentage of the group in whom reactions to each of the antigens were observed. Blastomycin is not included in the figure because no reactions to this antigen were observed in either the patient or the normal group. In the uremic subjects a total of 167 skin tests was performed, and 21 positive reactions were observed. In the 12 responsive recipients, 1.8 positive tests per patient were observed.
PATIENT M.S.P. The responses of the prospective donor group are also summarized in Figure 2 . The group was tested 167 times, and 73 positive reactions were recorded. All but one normal subject reacted to at least one antigen, and the mean frequency was 2.8 reactions per person.
The relationships between the responsive and unresponsive recipients with respect to their mean reaction times, mean ages, and the mean ischemia times of the transplanted kidneys are summarized in Table II Table III , the mean reaction time of these unresponsive recipients was 15.8 days. The mean reaction time of the remaining three unresponsive recipients was 13.0 days. Six of the 12 responsive recipients were transplanted with kidneys from genetically related donors, and the mean reaction time of these recipients was 4.5 days. The remaining six responsive patients who received kidneys from unrelated donors manifested attempted rejection at an average of 3.8 days.
The reaction times were also compared after all 26 patients had been divided on the basis of those whose donors were genetically related and those whose donors were not. These data are shown in the lower part of been possible in the reported instances of isohemagglutinin-mediated kidney rejection. If he is omitted from the responsive recipient group, the mean reaction time for the group becomes 4.5 days.
In general, the response of the recipients to the transplanted kidneys was similar, varying to an important degree only in the time of onset. In most instances, the changes in the various parameters of clinical and laboratory status outlined above occurred almost simultaneously, and, after review of the patients' clinical records, the onset of attempted rejection could be recognized with ease. Twenty-five of the 26 patients received therapy for reversal of rejection. The postoperative course of the exceptional patient (Patient 24) is summarized in Figure 3 The numbers of patients in each group who are alive at a minimum of 7 months after transplantation are summarized in Table V. Discussion Twenty-seven patients received kidney transplants from 29 donors at the University of Colorado Medical Center between June 27, 1963, and November 9, 1963. During this period, all patients were treated for attempted rejection on the basis of one protocol, namely, that immunosuppressive therapy in addition to azathioprine was not instituted until deterioration of kidney function was clearly apparent. Addition of patients to this study was stopped because of a change in the treatment protocol employed for subsequent recipients. The group comprising the present study includes 26 patients who survived the first 24 postoperative hours and who received kidneys that functioned well enough at the time of implantation to be left in place. One patient, who received a kidney from her father, was excluded from the study because she died approximately 12 hours postoperatively, and the cause of death was electrolyte imbalance occurring during a diuresis of over 18 L. Two patients included in the study (Patients 17 and 18) each received two kidney transplants. In both instances, the donors of the first kidney were not compatible with the recipients with respect to the ABO blood group antigens, and function of the kidney ceased within minutes after implantation. The two mismatched kidneys were removed at the time of the first opperations. Since the failure of these kidneys appeared to have been mediated by humoral antibody, their rejection was not considered further in this study. These two patients subsequently received second kidney transplants from unrelated volunteers, and the reaction times in response to these grafts were included in the evaluation of the group. No further exclusions were made in the remaining 26 because the postoperative deterioration of renal function was believed to have been the result of attempted allograft rejection. Because Patients 2, 3, and 24 had unusual features in their postoperative courses, the data have been evaluated both after including and excluding these patients.
Delayed cutaneous hypersensitivity is suppressed in patients with advanced renal failure (3) . By all parameters studied, the patients in this investigation had irreversible renal failure. Sixteen of the 19 patients in whom endogenous creatinine clearance was evaluated had values of less than 5 ml per minute, and in all patients the values were less than 10 ml per minute. In a study of the relationship of impaired creatinine clearance and life expectancy in patients with chronic kidney disease, Tobias, McLaughlin, and Hopper reported that only 2 of 17 patients with clearance values that remained below 10 ml per minute were alive 9 months later (8) . The seven patients who were not evaluated with respect to creatinine clearance had levels of blood urea nitrogen above 116 mg per 100 ml at the time of intradermal testing. The histologic appearance of the kidneys substantiated the severe degree of kidney destruction that had occurred.
In a study of delayed cutaneous hypersensitivity to tuberculin in seven uremic subjects, Dammin and co-workers concluded that delayed reactivity was not impaired in patients with chronic renal disease (2) . In the present investigation, 14 of the 26 uremic recipients were found to be unreactive to a panel of antigens. Only one of the normal subjects did not react to at least one of the antigens. The remaining 12 uremic patients, in whom delayed cutaneous hypersensitivity was de- A number of factors in addition to the immunologic capability of the recipient influence the survival of a kidney allograft. In general, elderly patients are less likely to be successful kidney allograft recipients than younger patients (9) . The chronically uremic older patient is less able to withstand the rigors of extensive abdominal surgery as well as the marked systemic insult associated with the rejection crisis. Presumably this difference with respect to age is related to the presence of more extensive degenerative vascular and cardiorespiratory disease. The present study indicates that the less favorable prognosis in older recipients is not related to a difference in their immunological response, since the reaction time was not significantly different in those over 35 years and those under 35 years. The mean age of the unresponsive recipient group was also not significantly different from the mean age of the responsive recipients (Table II ).
An excessive period of ischemia of a transplanted kidney may jeopardize its survival (9) . Although in animal studies the deleterious effect of ischemia is more pronounced on allografts than on autografts, the reaction times cannot be related to the ischemia times of the kidneys transplanted in this study. The reaction time to kidneys subjected to less than 40 minutes ischemia was the same as the reaction time to kidneys ischemic for more than 40 minutes. This inability to relate deterioration of function to ischemia time may indicate that ischemia does not enhance immunologic damage. Probably of more relevance is the fact that there was only one kidney exposed to an inordinately long period of ischemia (Patient 2). Whether this patient is included in the group or not, the ischemia times in the unresponsive and responsive groups are not significantly different (Tables II and IV ), indicating that ischemia does not influence the relationship reported between cutaneous sensitivity and attempted rejection.
Although matching of the ABO erythrocyte antigens of the donor with those of the recipient does not insure success of a kidney transplant, the insertion of a kidney from a mismatched donor is associated with a high failure rate (10) . Because of the rapidity of onset of the rejection of mismatched kidneys, the failure is believed to be primarily the result of the presence of circulating isoagglutinin. Only one patient (Patient 3) received a kidney from a donor mismatched with respect to ABO antigens. He was considered in this series because his kidney did function well immediately after insertion. However, the relationship of cutaneous reactivity to rejection has also been evaluated excluding this patient because the kidney did fail soon after implantation and the failure was associated with a fall in isoagglutinin titer. His exclusion from the group did not alter significantly the difference between the responsive and unresponsive groups (Table IV) .
Transplantation studies with laboratory animals have established the importance of the genetic relationship of the donor and recipient. Tissue allografts survive longer when transplanted between mice of strains that share major histocompatibility antigens than when they are exchanged between mice of strains that do not (11) . In addition, tolerance of tissue allografts is more easily induced when strains share major transplantation antigens ( 12) .
With respect to the present group of patients, the interval between transplantation and the immunologic response to the kidney did not correlate with the genetic relationship of the donor to the degree that would be expected from the studies with inbred mice. The mean reaction time observed in those recipients whose donors were related was longer than the mean observed in those whose donors were not (11.8 W\7hen the kidney recipients were divided on the basis of the degree of suppression of delayed cutaneous hypersensitivity, a high degree of correlation with the interval between transplantation and response to the kidney was observed (Tables  II and IV) . The correlation was much better than the correlation observed between the genetic relationship of the donor and the reaction time. This fact is interpreted to indicate that uremic suppression of delayed responsiveness is a factor which appears to supersede in importance the genetic relationship of the donor in determining the recipient's response to this graft during the early postoperative period.
The responsive and unresponsive categories were subdivided on the basis of the genetic relationship of the kidney donor. An attempt was made to evaluate the effect of uremic suppression of delayed responsiveness within the group whose kidney donors were related and also within the group whose donors were not (Table III) . A better correlation was observed within the unrelated donor group (p = < 0.001) than within the related donor group (p = 0.025). \When Cases 2 and 3 were excluded from the related donor group, the numbers of patients were too small to demonstrate a significant correlation (0.1 > p > 0.05). Because the numbers of patients are relatively small, conclusions must remain tentative, but apparently the suppressive effect of uremia is more easily demonstrated in the patients who receive kidneys from unrelated donors.
Two additional factors influence the response of laboratory animals and patients to allogeneous tissue grafts. Previous exposure to antigens of a graft may accelerate its rejection. Two patients in the unresponsive recipient group each received two kidney transplants. The reaction times following insertion of the second kidneys were well within the range for the total group of unresponsive recipients. As well as can be determined, all patients were subjected to the same probability of sensitization from leukocytes in transfused blood.
The remaining factor is the degree of immunosuppression induced by chemotherapy. This is difficult to quantitate. Azathioprine was administered on a weight basis initially, and deviations from this dose were dictated by the peripheral b)lood0 counts. The aimi of treatment was to keel) the peripheral leukocyte count in the low normal range. Within this framework all patients received a similar amount of cytotoxic therapy.
With all the variables that are known to influence the survival of tissue allografts considered and those patients who conceivably could have constituted exceptions excluded, it appears clear that the chronically uremic patients with the most profound suppression of delayed cutaneous hypersensitivity manifest attempted rejection later than those patients with less suppression. Patients with Hodgkin's disease also have impaired delayed cutaneous reactivity and have impaired ability to reject skin allografts. In a study that compared these two abnormalities in patients with Hodgkin's disease, skin graft survival was most prolonged in the patients with complete suppression of delayed cutaneous responsiveness (13) . The pathogenesis of impaired immunologic capability has not been completely characterized in either chronic uremia or Hodgkin's disease. The mechanism does not appear to be the same in the two diseases. Delayed cutaneous reactivity cannot be acquired by patients with Hodgkin's disease through passive transfer of immunologically competent cells (13) . Chronically uremic patients, however, passively acquire delayed cutaneous reactivity as a consequence of the transfer of immunologically competent cells from kidney donors (3) .
A relationship between the ability of the chronically uremic patient to manifest delayed cutaneous hypersensitivity and his ability to respond to a transplanted kidney raises a number of important implications. First, the correlation of impaired delayed cutaneous reactivity with the reaction time suggests that the deterioration in renal function that occurred postoperatively in these patients was immunologically mediated, and not the result of failure of vascular anastomoses or other technical factors. Although graft rejection is clearly an immunologic phenomenon, the exclusion of other causes of abrupt deterioration in kidney function in the postoperative period is frequently a difficult clinical problem.
In a number of laboratory models, the successful induction of tolerance depends upon the degree of immune suppression at the time that antigen is introduced as a tolerance-conferring stimulus. To determine the possible role of uremic suppression of immunologic responsiveness in the ultimate fate of human kidney transplants, the overall survival of this group of patients was examined. A minimum of 7 months has elapsed since transplantation. Although the primary cause of death was not the result of renal failure following graft rejection, the immunologic response to the kidney may be considered to have been a frequent underlying cause of death. In general, patients with the most intensive immunologic response receive more immunosuppressive therapy, and hence are more subject to fatal infections and bone marrow depression. Ten of 14 unresponsive recipients and 5 of 12 responsive recipients are alive at present. These differences are not significant. In addition, a comparison of the unresponsive group to the responsive group is difficult to interpret because of the preponderance of patients with related donors in the unresponsive group. The genetic relationship of the donor has been established to be an important factor in the long term survival of the human kidney allograft recipient.
Survival data with subdivision of the groups on the basis of donor genetic relationship are summarized in Table V . In each category the unresponsive recipients appear to have a better prognosis, but the differences are not statistically significant. However, it should not be concluded that suppression of the recipient's immunologic responsiveness as a consequence of advanced renal failure has no effect on the ultimate fate of the graft. The majority of patients appeared to have some suppression of delayed cutaneous hypersensitivity, and in this study an attempt has been made to distinguish between two degrees of suppression.
A final implication of the present observations is that they provide a method for the identification of those patients in whom difficulty can be anticipated in the early postoperative period. Adrenal steroid therapy will suppress delayed cutaneous reactivity and its value in the treatment of the rejection crisis has been recently reviewed (14) . We might expect that, if the treatment given to the present group of patients to reverse rejection had been instituted in the responsive recipients at the time of transplantation, the immunologic response during the postoperative period would have been delayed. The suppressive influence of the steroid could be provided early in the evolution of the rejection reaction rather than after the immunologic reaction had become well established. This concept is under evaluation in a group of patients currently receiving allogeneous kidney grafts.
Summary
Twenty-six patients with chronic uremia were studied with respect to their ability to demonstrate delayed cutaneous hypersensitivity reactions to a panel of antigens. All of the patients subsequently received kidney allografts from living donors. Those patients in whom delayed hypersensitivity reactions could be demonstrated, the responsive group, manifested evidence of attempted allograft rejection significantly earlier than those patients with no reactions, the unresponsive group (4.2 days vs. 15.2 days). These differences were independent of the duration of ischemia of the transplanted kidney, the age of the patient, and the relationship of the donor to the recipient. These observations suggest that the chronically uremic patient with the most profound reduction in delayed cutaneous responsiveness is also less able to respond to a kidney allograft. The clinical implications of these observations are discussed.
